Latest Middle East Market News

Osteopore has inked a three-year distribution agreement with Al-Umnia Medical to bring its 3D-printed orthopaedic implants to five Gulf countries, targeting a rapidly expanding regional market.

OncoSil Medical has gained Saudi FDA approval for its OncoSil™ device, enabling full reimbursement and commercial access in Saudi Arabia, the Middle East's largest healthcare market.

1414 Degrees has formed an Aerospace, Drone & Defence Advisory Board featuring six veterans from top defence and aerospace firms to accelerate the rollout of its SiNTL silicon anode battery technology targeting drones and adjacent markets.

X2M Connect has secured $1.49 million in its second tranche placement and plans to issue additional options to investors, pending shareholder approval, to support its expanding smart city technology ambitions.

Gentrack’s airport technology arm Veovo is acquiring Dubai Technology Partners for US$10 million, boosting its AI portfolio and regional presence in the Middle East.

Orbital UAV has entered the Middle East market with a USD 1.1 million order from a UAE sovereign government for its 50HFE propulsion systems and signed a long-term distribution agreement to expand its UAV propulsion presence.

Starpharma reports a $1.37 million profit for H1 FY26, driven by a major upfront payment from Genentech and progress in its radiopharmaceutical pipeline. The biotech also expands its consumer health footprint amid growing partnerships.

SRJ Technologies has completed the first phase of its growth strategy and is now advancing into market penetration with a significant $23.8 million joint venture in the Middle East and a key board appointment.

SRJ Technologies’ UAE subsidiary has landed a US$879k contract to manage a major controls upgrade for a Middle Eastern National Oil Company, marking a key step in its regional expansion.

Memphasys has inked a five-year exclusive distribution agreement with Middle East leader ITL, unlocking a $325,000 initial order for its Felix™ fertility system upon CE Mark approval. This deal opens access to 15 countries and over 350 IVF clinics, setting the stage for rapid regional adoption.

Gale Pacific’s FY25 results reveal resilience amid US market challenges, with growth in Australia and the Middle East offsetting tariff impacts and prompting a major US operating restructure.

X2M Connect reports a 43% revenue decline in FY25 but improves gross margins and expands into the Middle East and renewable energy sectors, setting a positive outlook for FY26.